• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. In Vitro Activity of Calcineurin and Heat-Shock Protein 90 (Hsp90) Inhibitors Against Aspergillus fumigatus Azole- and Ec

Giuseppe

Emeritus
[Source: Antimicrobial Agents Chemotherapy, full text: (LINK). Abstract, edited.]

In Vitro Activity of Calcineurin and Heat-Shock Protein 90 (Hsp90) Inhibitors Against Aspergillus fumigatus Azole- and Echinocandin-Resistant Strains

Fr?d?ric Lamoth 1, Praveen R. Juvvadi 1, Christopher Gehrke 1 and William J. Steinbach 1,2,*

Author Affiliations: <SUP>1</SUP>Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA; <SUP>2</SUP>Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USA



ABSTRACT

Due to the limited number of antifungals and the emergence of resistance, new therapies against invasive aspergillosis are needed. We show that calcineurin inhibitors are active in vitro against both Aspergillus fumigatus azole- and echinocandin-resistant strains. The Hsp90 inhibitor geldanamycin had modest activity when used alone, but its combination with caspofungin or FK506 resulted in fungicidal activity against azole-resistant strains. Targeting the Hsp90-calcineurin axis is a promising alternative strategy against azole-resistant A. fumigatus strains.



FOOTNOTES

*Corresponding author: William J. Steinbach, Division of Pediatric Infectious Diseases, 427 Jones Building, Research Drive, Duke University Medical Center, Durham, NC 27710, Phone number: (919) 681-1504, Fax number: (919) 668-4859, E-mail: bill.steinbach@duke.edu

Copyright ? 2012, American Society for Microbiology. All Rights Reserved.
-
-------
 
Back
Top Bottom